MENU
+Compare
CVAC
Stock ticker: NASDAQ
AS OF
Aug 8 closing price
Price
$5.44
Change
-$0.02 (-0.37%)
Capitalization
1.22B

CVAC CureVac NV Forecast, Technical & Fundamental Analysis

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people... Show more

CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CVAC with price predictions
Aug 08, 2025

CVAC in +1.11% Uptrend, advancing for three consecutive days on July 23, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CVAC advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 42 cases where CVAC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CVAC as a result. In of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVAC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CVAC broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CVAC entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.624) is normal, around the industry mean (18.662). P/E Ratio (5.831) is within average values for comparable stocks, (54.033). CVAC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.909). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (2.008) is also within normal values, averaging (286.048).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVAC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVAC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CVAC is expected to report earnings to fall 80.04% to -4 cents per share on August 14

CureVac NV CVAC Stock Earnings Reports
Q2'25
Est.
$-0.05
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.09
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.04
The last earnings report on May 20 showed earnings per share of -23 cents, missing the estimate of -16 cents. With 259.11K shares outstanding, the current market capitalization sits at 1.22B.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company developing tumour immunotherapy

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Friedrich-Miescher-Strasse 15
Phone
+49 707198830
Employees
1049
Web
https://www.curevac.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLPFX8.880.02
+0.23%
Invesco SteelPath MLP Select 40 A
BTMFX25.040.05
+0.20%
Boston Trust Midcap
PRSVX51.840.08
+0.15%
T. Rowe Price Small-Cap Value
SLGCX5.80N/A
N/A
Saratoga Large Capitalization Growth C
ARBNX14.11-0.01
-0.07%
Arbitrage I

CVAC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with AIM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
-0.37%
AIM - CVAC
44%
Loosely correlated
-8.09%
BNTX - CVAC
40%
Loosely correlated
+0.28%
IMNM - CVAC
39%
Loosely correlated
-1.82%
MRNA - CVAC
39%
Loosely correlated
-1.84%
ARCT - CVAC
38%
Loosely correlated
-0.58%
More